COSCIENS Biopharma Inc T.AEZ

RE:RE:RE:RE:A Big Thank you to Proph

[prophetoffactz]

This is who AEZS hired for its NMOSD program...

Dr. Michael Levy is a leading expert in neuromyelitis optica spectrum disorder (NMOSD) and other neuroimmunological conditions at Massachusetts General Hospital. Here are the key points about his work on NMOSD:

1. Dr. Levy is the Research Director of the Division of Neuroimmunology & Neuroinfectious Disease at Massachusetts General Hospital and an Associate Professor at Harvard Medical School.
2. He specializes in rare autoimmune diseases of the central nervous system, including NMOSD, MOG antibody disease, and transverse myelitis.
3. Dr. Levy established the first NMOSD clinic in New England at Massachusetts General Hospital, providing specialized care for patients with these rare conditions.
4. His research focuses on understanding the immunopathogenic mechanisms of NMOSD and related disorders, with the goal of translating findings into human trials.
5. Dr. Levy has been instrumental in improving the diagnosis and treatment of NMOSD. He notes that in the past, about 95% of NMOSD cases were misdiagnosed as multiple sclerosis (MS), leading to inappropriate treatments that could worsen the condition.
6. He emphasizes the importance of distinguishing NMOSD from MS, as the diseases have different immunological bases and require distinct treatment approaches.
7. Dr. Levy's clinic participates in clinical trials for new NMOSD treatments and diagnostic tools.
8. He is involved in education and outreach efforts to raise awareness about NMOSD and related disorders among both medical professionals and the public.
9. Dr. Levy's work has contributed to the understanding that NMOSD disproportionately affects certain populations, such as people of African descent and women.

Through his clinical work, research, and educational efforts, Dr. Levy has significantly advanced the field of NMOSD treatment and research at Massachusetts General Hospital and beyond.